RedHill Biopharma reported $214K in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
Cronos Group USD 2.01M 159K Jun/2025
RedHill Biopharma USD 214K 142K Jun/2025